# Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD

> **NCT07643974** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Medstar Health Research Institute** · enrollment: 48 (estimated)

## Conditions studied

- Spinal Cord Injury
- Neurogenic Bladder (NB)
- Neurogenic Lower Urinary Tract Dysfunction
- Multiple Sclerosis
- Spina Bifida
- Urinary Tract Infection(UTI)

## Interventions

- **DRUG:** Gentamicin
- **DRUG:** Lactobacillus Rhamnosus GG

## Key facts

- **NCT ID:** NCT07643974
- **Lead sponsor:** Medstar Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-08-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07643974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07643974, "Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07643974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*